|
|
Name: |
5AM Venture Management LLC |
City: |
San Francisco |
State: |
CA |
Zip: |
94107 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
32 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
TRDA |
Entrada Therapeutics, Inc. |
1 |
- |
$0.00 |
$39,852,000 |
4,408,379 |
15.07% |
-36,369,000 |
0 |
14.124 |
N/A |
|
ELVN |
Enliven Therapeutics Ord Shs |
2 |
- |
$0.00 |
$26,026,000 |
1,322,477 |
9.84% |
-10,644,000 |
-307,288 |
2.632 |
N/A |
|
DNTH |
Dianthus Therapeutics Ord Shs |
3 |
- |
$0.70 |
$18,643,000 |
1,027,711 |
7.05% |
-3,761,000 |
0 |
3.162 |
N/A |
|
SKYE |
Skye Bioscience Inc |
4 |
- |
$4.17 |
$15,762,000 |
9,913,168 |
5.96% |
-12,292,000 |
0 |
35.32 |
N/A |
|
PHVS |
Pharvaris N V Ord Shs |
5 |
- |
$0.00 |
$12,522,000 |
797,600 |
4.74% |
-2,768,000 |
0 |
0.193 |
N/A |
|
CNTA |
Centessa Pharmaceuticals Plc |
6 |
- |
$0.00 |
$11,949,000 |
830,945 |
4.52% |
-1,969,000 |
0 |
0.634 |
N/A |
|
CAMP |
Camp4 Therapeutics Corp |
7 |
- |
$1.35 |
$11,712,000 |
2,927,915 |
4.43% |
-3,572,000 |
0 |
14.523 |
N/A |
|
BHVN |
Biohaven Ltd. |
8 |
- |
$14.76 |
$11,514,000 |
478,972 |
4.35% |
-6,376,000 |
0 |
0.507 |
N/A |
|
MLTX |
Multisys Language Solutions... |
9 |
- |
$0.00 |
$11,030,000 |
282,313 |
4.17% |
-4,257,000 |
0 |
0.449 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
10 |
- |
$15.23 |
$9,929,000 |
736,595 |
3.76% |
-4,192,000 |
0 |
0.818 |
N/A |
|
TECX |
Tectonic Therapeutic Inc |
11 |
- |
$21.09 |
$9,061,000 |
511,660 |
3.43% |
-18,487,000 |
-85,000 |
3.474 |
N/A |
|
CLDX |
Celldex Therapeutics Inc |
12 |
- |
$22.11 |
$9,025,000 |
497,270 |
3.41% |
-3,541,000 |
0 |
0.674 |
Diagnostic Substances |
|
TYRA |
Tyra Biosciences, Inc. |
13 |
- |
$0.00 |
$8,735,000 |
939,298 |
3.3% |
-4,321,000 |
0 |
1.781 |
N/A |
|
ERAS |
Erasca, Inc. |
14 |
- |
$1.45 |
$7,405,000 |
5,405,404 |
2.8% |
-6,163,000 |
0 |
1.914 |
N/A |
|
ARTV |
Artiva Biotherapeutics, Inc. |
15 |
- |
$0.00 |
$7,060,000 |
2,353,304 |
2.67% |
-16,661,000 |
0 |
9.686 |
N/A |
|
ANAB |
Anaptysbio Inc |
16 |
- |
$23.88 |
$6,650,000 |
357,733 |
2.52% |
1,914,000 |
0 |
1.022 |
N/A |
|
PRAX |
Praxis Precision Medicines,... |
17 |
- |
$0.00 |
$6,438,000 |
170,000 |
2.43% |
-6,645,000 |
0 |
0.324 |
N/A |
|
GHRS |
Gh Research Ord Shs |
18 |
- |
$0.00 |
$6,316,000 |
572,665 |
2.39% |
2,307,000 |
0 |
1.172 |
N/A |
|
EYPT |
EyePoint Pharmaceuticals Inc |
19 |
- |
$0.44 |
$5,691,000 |
1,050,000 |
2.15% |
-2,132,000 |
0 |
0.732 |
Biotechnology |
|
VKTX |
Viking Therapeutics, Inc. |
20 |
- |
$27.72 |
$4,579,000 |
189,593 |
1.73% |
-3,050,000 |
0 |
0.189 |
N/A |
|
VOR |
Vor Biopharma Inc. |
21 |
- |
$0.00 |
$4,565,000 |
6,361,723 |
1.73% |
-2,497,000 |
0 |
9.69 |
N/A |
|
SRZN |
Surrozen Ord Shs |
22 |
New |
$0.50 |
$3,615,000 |
310,000 |
1.37% |
3,615,000 |
310,000 |
0.885 |
N/A |
|
TARA |
Protara Therapeutics, Inc |
23 |
- |
$2.78 |
$3,408,000 |
800,000 |
1.29% |
-816,000 |
0 |
7.612 |
N/A |
|
SCPH |
Scpharmaceuticals Inc. |
24 |
- |
$0.00 |
$3,158,000 |
1,200,647 |
1.19% |
-1,092,000 |
0 |
2.401 |
N/A |
|
RLYB |
Rallybio Corp |
25 |
- |
$0.00 |
$2,376,000 |
3,630,724 |
0.9% |
-1,109,000 |
0 |
10.518 |
N/A |
|
ADVM |
Adverum Biotechnologies, Inc |
26 |
- |
$2.26 |
$2,367,000 |
541,666 |
0.9% |
-163,000 |
0 |
0.536 |
N/A |
|
SLN |
Silence Therapeutics Adr Re... |
27 |
- |
$0.00 |
$1,343,000 |
476,200 |
0.51% |
-1,933,000 |
0 |
1.597 |
N/A |
|
ALEC |
Alector, Inc. |
28 |
- |
$1.50 |
$1,225,000 |
995,841 |
0.46% |
-657,000 |
0 |
1.257 |
N/A |
|
CDTX |
Cidara Therapeutics, Inc. |
29 |
- |
$47.87 |
$1,222,000 |
56,725 |
0.46% |
-303,000 |
0 |
1.244 |
N/A |
|
ZNTL |
Zentalis Pharmaceuticals, Llc |
30 |
- |
$1.24 |
$779,000 |
490,000 |
0.29% |
-706,000 |
0 |
0.564 |
N/A |
|
MRSN |
Mersana Therapeutics, Inc. |
31 |
- |
$0.28 |
$449,000 |
1,305,000 |
0.17% |
-1,417,000 |
0 |
1.082 |
N/A |
|
AKRO |
Akero Therapeutics, Inc. |
32 |
Closed |
$0.00 |
$0 |
0 |
0% |
-4,590,000 |
-165,000 |
0 |
N/A |
|